Jones Trading Initiates Coverage On Regulus Therapeutics With Buy Rating, Announces Price Target of $8
Jones Trading Initiates Coverage On Regulus Therapeutics With Buy Rating, Announces Price Target of $8
瓊斯交易以買入評級啓動對Regulus Therapeutics的報道，宣佈目標股價爲8美元
Jones Trading analyst Catherine Novack initiates coverage on Regulus Therapeutics (NASDAQ:RGLS) with a Buy rating and announces Price Target of $8.
瓊斯交易分析師凱瑟琳·諾瓦克開始對Regulus Therapeutics（納斯達克股票代碼：RGLS）進行報道，評級爲買入，並宣佈目標股價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。